Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Nuvalent, Inc.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/06/2023 |
4
| Turner Christopher Durant (Chief Medical Officer) has filed a Form 4 on Nuvalent, Inc.|
Txns:
| Sold 2,665 shares
@ $51.32, valued at
$136.8k
Sold 2,265 shares
@ $53.7, valued at
$121.6k
Sold 600 shares
@ $54.32, valued at
$32.6k
Sold 500 shares
@ $55.84, valued at
$27.9k
Sold 500 shares
@ $57.18, valued at
$28.6k
Sold 1,465 shares
@ $57.7, valued at
$84.5k
Exercised 7,995 options to buy
@ $6.89, valued at
$55.1k
|
|
| 10/06/2023 |
4
| Noci Darlene (Chief Development Officer) has filed a Form 4 on Nuvalent, Inc.|
Txns:
| Sold 14,600 shares
@ $55.41, valued at
$809k
Sold 5,400 shares
@ $57.54, valued at
$310.7k
Exercised 4,587 options to buy
@ $1.08, valued at
$5k
Exercised 15,413 options to buy
@ $6.89, valued at
$106.2k
|
|
| 10/04/2023 |
4
| Noci Darlene (Chief Development Officer) has filed a Form 4 on Nuvalent, Inc.|
Txns:
| Sold 745 shares
@ $45.35, valued at
$33.8k
Sold 2,144 shares
@ $46.01, valued at
$98.6k
Sold 111 shares
@ $47.01, valued at
$5.2k
Exercised 3,000 options to buy
@ $1.08, valued at
$3.2k
|
|
| 08/17/2023 |
4
| Miller Deborah Ann (Chief Legal Officer) has filed a Form 4 on Nuvalent, Inc.|
Txns:
| Sold 1,291 shares
@ $42.46, valued at
$54.8k
Sold 709 shares
@ $43.01, valued at
$30.5k
Exercised 2,000 options to buy
@ $6.89, valued at
$13.8k
|
|
| 08/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/28/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/24/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/06/2023 |
4
| Noci Darlene (Chief Development Officer) has filed a Form 4 on Nuvalent, Inc.|
Txns:
| Sold 2,447 shares
@ $41.33, valued at
$101.1k
Sold 553 shares
@ $42.12, valued at
$23.3k
Exercised 3,000 options to buy
@ $1.08, valued at
$3.2k
|
|
| 06/16/2023 |
4
| Flynn James E (10% Owner) has filed a Form 4 on Nuvalent, Inc.|
Txns:
| Granted 15,000 options to buy
@ $44.68, valued at
$670.2k
|
|
| 06/16/2023 |
4
| Hack Andrew A. F. (Director) has filed a Form 4 on Nuvalent, Inc.|
Txns:
| Granted 15,000 options to buy
@ $44.68, valued at
$670.2k
|
|
| 06/16/2023 |
4
| Wheeler Cameron (Director) has filed a Form 4 on Nuvalent, Inc.|
Txns:
| Granted 15,000 options to buy
@ $44.68, valued at
$670.2k
|
|
| 06/16/2023 |
4
| Pearlberg Joseph (Director) has filed a Form 4 on Nuvalent, Inc.|
Txns:
| Granted 15,000 options to buy
@ $44.68, valued at
$670.2k
|
|
| 06/16/2023 |
4
| Srivastava Sapna (Director) has filed a Form 4 on Nuvalent, Inc.|
Txns:
| Granted 15,000 options to buy
@ $44.68, valued at
$670.2k
|
|
| 06/16/2023 |
4
| Shair Matthew (Director) has filed a Form 4 on Nuvalent, Inc.|
Txns:
| Granted 15,000 options to buy
@ $44.68, valued at
$670.2k
|
|
| 06/16/2023 |
4
| Protopapas Anna (Director) has filed a Form 4 on Nuvalent, Inc.|
Txns:
| Granted 15,000 options to buy
@ $44.68, valued at
$670.2k
|
|
| 06/16/2023 |
4
| Meyers Michael L. (Director) has filed a Form 4 on Nuvalent, Inc.|
Txns:
| Granted 15,000 options to buy
@ $44.68, valued at
$670.2k
|
|
| 06/16/2023 |
4
| Gilliland Dwight Gary (Director) has filed a Form 4 on Nuvalent, Inc.|
Txns:
| Granted 15,000 options to buy
@ $44.68, valued at
$670.2k
|
|
| 06/16/2023 |
4
| Conley Emily (Director) has filed a Form 4 on Nuvalent, Inc.|
Txns:
| Granted 15,000 options to buy
@ $44.68, valued at
$670.2k
|
|
| 06/07/2023 |
4
| Turner Christopher Durant (Chief Medical Officer) has filed a Form 4 on Nuvalent, Inc.|
Txns:
| Sold 10,235 shares
@ $44.86, valued at
$459.1k
Exercised 10,235 options to buy
@ $6.89, valued at
$70.5k
|
|
| 06/07/2023 |
4
| Noci Darlene (Chief Development Officer) has filed a Form 4 on Nuvalent, Inc.|
Txns:
| Sold 600 shares
@ $45, valued at
$27k
Exercised 600 options to buy
@ $1.08, valued at
$648 |
|
| 06/02/2023 |
4
| Noci Darlene (Chief Development Officer) has filed a Form 4 on Nuvalent, Inc.|
Txns:
| Sold 239 shares
@ $41.46, valued at
$9.9k
Sold 1,389 shares
@ $42.36, valued at
$58.8k
Sold 1,372 shares
@ $43.13, valued at
$59.2k
Exercised 3,000 options to buy
@ $1.08, valued at
$3.2k
|
|
| 05/17/2023 |
4
| Miller Deborah Ann (Chief Legal Officer) has filed a Form 4 on Nuvalent, Inc.|
Txns:
| Sold 502 shares
@ $40.31, valued at
$20.2k
Sold 1,498 shares
@ $40.89, valued at
$61.3k
Exercised 2,000 options to buy
@ $6.89, valued at
$13.8k
|
|
| 05/09/2023 |
4
| Miller Deborah Ann (Chief Legal Officer) has filed a Form 4 on Nuvalent, Inc.|
Txns:
| Sold 2,800 shares
@ $39.64, valued at
$111k
Sold 1,332 shares
@ $39.63, valued at
$52.8k
Exercised 2,800 options to buy
@ $6.89, valued at
$19.3k
Exercised 1,332 options to buy
@ $6.89, valued at
$9.2k
|
|
| 05/03/2023 |
4
| Noci Darlene (Chief Development Officer) has filed a Form 4 on Nuvalent, Inc.|
Txns:
| Sold 28 shares
@ $35.71, valued at
$999.9
Sold 91 shares
@ $36.98, valued at
$3.4k
Sold 549 shares
@ $38.03, valued at
$20.9k
Sold 2,282 shares
@ $38.81, valued at
$88.6k
Sold 50 shares
@ $39.58, valued at
$2k
Exercised 3,000 options to buy
@ $1.08, valued at
$3.2k
|
|
| 05/03/2023 |
4
| Miller Deborah Ann (Chief Legal Officer) has filed a Form 4 on Nuvalent, Inc.|
Txns:
| Sold 900 shares
@ $39.61, valued at
$35.6k
Exercised 900 options to buy
@ $6.89, valued at
$6.2k
|
|
| 04/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/05/2023 |
4
| Noci Darlene (Chief Development Officer) has filed a Form 4 on Nuvalent, Inc.|
Txns:
| Sold 2,888 shares
@ $26.57, valued at
$76.7k
Sold 112 shares
@ $27.06, valued at
$3k
Exercised 3,000 options to buy
@ $1.08, valued at
$3.2k
|
|
| 03/17/2023 |
4
| Miller Deborah Ann (Chief Legal Officer) has filed a Form 4 on Nuvalent, Inc.|
Txns:
| Sold 1,839 shares
@ $28.17, valued at
$51.8k
Sold 161 shares
@ $29.22, valued at
$4.7k
Exercised 2,000 options to buy
@ $6.89, valued at
$13.8k
|
|
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/19/2023 |
4
| Miller Deborah Ann (Chief Legal Officer) has filed a Form 4 on Nuvalent, Inc.|
Txns:
| Sold 709 shares
@ $32.15, valued at
$22.8k
Sold 1,291 shares
@ $32.88, valued at
$42.4k
Exercised 2,000 options to buy
@ $6.89, valued at
$13.8k
|
|
|
|
|